Coupons and vouchers for name-brand prescription drugs claim to cut costly out-of-pocket expenses, but they actually may be doing very little to control prices.
Coupons and vouchers for name-brand prescription drugs claim to cut costly out-of-pocket expenses, but they actually may be doing very little to control prices.
There are several reasons for the absence of actual savings. Most available coupons only cover 3-months’ supply or less of a drug, meaning the remaining refills are at full cost. Switching to a generic form of a brand-name drug is difficult for most patients. Doctors also may not be communicating about lower-cost alternatives to patients.
“Once a coupon program ends, patients with chronic diseases face copayments for these brand-name medications that are higher than those for generic alternatives,” read a recent report. “By that point, however, patients may have developed loyalty to the particular brand or may be skeptical about switching away from a medication that they perceive as effective—or they may not even be aware of alternative therapies.”
As well, because brand-name drugs typically cost more for payers, costs are then passed on to consumers through higher premiums. “The more that patients use drug coupons to obtain brand-name medications when lower-cost alternatives are available,” the report continued, “the more expenses will rise for their insurers. A predictable response from the insurers would be to raise coverage rates for all patients.”
Patients' medication adherence is likely to suffer in the absence of any discounts. Matthew Bennett, senior vice president of the Pharmaceutical Research and Manufacturers of America, says, "Today's high levels of cost sharing can pose a significant access barrier for patients, resulting in low adherence and poor health outcomes."
To ensure medication adherence does not falter due to costs, physicians must ensure consumers are aware of both the benefits and pitfalls of using prescription drug coupons.The report concluded, “Physicians need to talk to their commercially insured patients about the implications of drug-coupon use and make sure that their inclination to reduce short-term out-of-pocket spending doesn’t come at the cost of higher long-term expenses for themselves and society."
Around the Web
Check Up: Prescription-discount Coupons Have Hidden Costs [Philly.com]
Do Prescription Drug Coupons Lead To Higher Insurance Rates For Everyone? [The Consumerist]
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease
November 20th 2024Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.
Read More